Answers are grounded in this paper and cite their sources.
Turkish Archives of PediatricsGaucher disease (GD) is an autosomal recessive lysosomal storage disorder caused by glucocerebrosidase deficiency; type 2 (GD2), the acute neuronopathic form, is its rarest and most severe subtype, 1 typically presenting between 3 and 6 months of age with hepatosplenomegaly, feeding difficulties, and progressive neurological deterioration.2,3 Neonatal cholestasis is an exceptionally uncommon initial manifestation of GD2, and its recognition is frequently delayed because bone marrow aspirates may lack visible Gaucher cells and clinical findings overlap with more common causes of neonatal liver disease.4,5 The authors describe a neonate with GD2 presenting as severe cholestasis from the third day of life to illustrate 2 points of practical importance: first, that neonatal cholestasis can be the earliest and most severe presentation of GD2, distinct from its more typical infantile neurological onset; and second, that a negative bone marrow examination does not exclude the diagnosis, so that enzymatic and molecular testing should be pursued whenever the clinical phenotype is suggestive.
No takes yet. Share an insight, caveat, or question.
Zdraveska et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: